Patients

Key to successful digital outreach: think small

Key to successful digital outreach: think small

By

Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.

Healthcare organization makes big data bigger

Credit card and loyalty program purchases will help Carolinas HealthCare System flag potential patient behavior issues.

Teva converts Copaxone users

The drugmaker's outreach efforts involve switching patients to the latest—and patented—Copaxone formulation.

Study links adherence with side effect worries

A study showed that side-effect fears keep asthmatics from sticking to medication regimens.

Remedy debuts long-form sponsored stories

Remedy debuts long-form sponsored stories

By

The publisher aims to bring patient stories to life through long-form multimedia narratives.

Mobile makes users more likely to switch brands: survey

Mobile makes users more likely to switch brands: survey

By

Smartphone users, while in the exam room, are more apt to be in "switch mentality," a study finds.

Can we handle cost of a healthy, aging population?

Can we handle cost of a healthy, aging population?

By

The short answer: we're not financially prepared for a slowly aging, healthy population, according to a recently published analysis.

Retail pharmacies up consumer satisfaction

Retail pharmacies up consumer satisfaction

By

A study shows consumers are increasingly pleased with retail pharmacies, compared to mail order pharmacies, which are often considered a key means of driving adherence and lowering healthcare coverage costs.

Research tool taps patient KOLs via mobile

Research tool taps patient KOLs via mobile

By

The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.

GSK and nonprofit shrink Big Data down to size

GSK and nonprofit shrink Big Data down to size

By

The partnership seeks to improve medication adherence through predictive analytics.

Business briefs: AbbVie, FDA, and health spending projections

AbbVie and Galapagos go after cystic fibrosis; FDA's NME approval pace slows; government shutdown could slow ad-com votes; and a report shows privately insured patients had emptier pockets in 2012 than 2011

Patient power taking center stage at event

Patient power taking center stage at event

By

An upcoming leadership summit is devoted to exploring whether health social media is driving meaningful change, as well as new ways to engage with health activists.

Researchers propose new Rx adherence model

Researchers propose new Rx adherence model

By

Researchers say using additional data points offers greater insight into patient-adherence patterns.

Blogs may smooth ups, downs of breast cancer: study

By

For women suffering from breast cancer, online tools appeared to be helpful in battling depression, a randomized trial showed.

Game for cancer patients gets mobile app

Game for cancer patients gets mobile app

By

Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.

Rampant dissatisfaction with psoriasis drugs: study

Rampant dissatisfaction with psoriasis drugs: study

By

Sales may be rising, but a new study finds current psoriasis therapies leave room for improvement. Over half of patients said they want better options.

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

By

The state's first patient portal has officially entered development, and the e-health firm leading the effort said that a former WebMD executive joined its board.

A Parkinson's app for patients that took its cue from HCPs

A Parkinson's app for patients that took its cue from HCPs

By

Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.

The complexity of cracking open the data door

The complexity of cracking open the data door

By

Companies are moving toward more access to clinical trial data. Despite their new stance, the internal battles haven't quite ended, some say.

Business briefs: GSK, UCB, AZ, Biogen Idec, CVS, Roche, Forest

China's industry investigation widens beyond GlaxoSmithKline; PhRMA's European equivalent rallies patient groups to fight transparency; Biogen Idec says a patient's death is not linked to Tecfidera; parents swap walk-in clinics for office visit; Roche continues its CEO hunt; and Forest logs 6% sales growth.

High deductibles linked to lower Rx fills and cancer screenings

By

A study highlights medical service trends among patients with high-deductible plans but lacks insight on health impact and long-term costs.

Impact and importance of patient preference still TBD

By

JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.

FDA gut-checks DTC clarity

By

The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.

Studies show cheaper drugs don't add up to greater use

By

Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.

WebMD on the hunt for new business

WebMD on the hunt for new business

By

The CEO's unexpected departure is part of the health information brand's latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.

FDA streamlines patient access information

By

A new FDA site gives patients a one-stop shop for commenting on pending regulations, finding clinical trials and navigating treatment options.

Docs haven't mellowed on DTC, snap poll suggests

Docs haven't mellowed on DTC, snap poll suggests

By

The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.

Business Briefs: Manhattan Research, KPMG, Scioderm and GSK

Health-seeking consumers continue social-media push; Scioderm scores FDA's "Breakthrough" designation for bullosa agent; and GSK files NDA for airway treatment.

It's Consumer's Choices as Guidelines Change

It's Consumer's Choices as Guidelines Change

Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.

Diagnosing pricing issues

By

CDC figures suggest patients are avoiding medications to save money, and show that out-of-pocket costs for US consumers are rising faster than those for consumers in many other countries

Email Newsletters